Annual Total Liabilities
$345.20 K
-$563.20 K-62.00%
March 1, 2024
Summary
- As of February 26, 2025, VRAX annual total liabilities is $345.20 thousand, with the most recent change of -$563.20 thousand (-62.00%) on March 1, 2024.
- During the last 3 years, VRAX annual total liabilities has fallen by -$526.20 thousand (-60.39%).
- VRAX annual total liabilities is now -72.28% below its all-time high of $1.25 million, reached on March 31, 2022.
Performance
VRAX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.03 M
+$680.90 K+197.25%
September 1, 2024
Summary
- As of February 26, 2025, VRAX quarterly total liabilities is $1.03 million, with the most recent change of +$680.90 thousand (+197.25%) on September 1, 2024.
- Over the past year, VRAX quarterly total liabilities has stayed the same.
- VRAX quarterly total liabilities is now -17.61% below its all-time high of $1.25 million, reached on March 31, 2022.
Performance
VRAX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VRAX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.0% | 0.0% |
| 3 y3 years | -60.4% | 0.0% |
| 5 y5 years | -72.1% | 0.0% |
VRAX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.3% | at low | -17.6% | +197.3% |
| 5 y | 5-year | -72.3% | at low | -17.6% | +197.3% |
| alltime | all time | -72.3% | at low | -17.6% | +197.3% |
Virax Biolabs Group Limited Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.03 M(+197.2%) |
| Mar 2024 | $345.20 K(-62.0%) | $345.20 K(-62.4%) |
| Sep 2023 | - | $919.00 K(+1.2%) |
| Mar 2023 | $908.40 K | $908.40 K(-20.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.14 M(-8.3%) |
| Mar 2022 | $1.25 M(+42.9%) | $1.25 M(+19.1%) |
| Sep 2021 | - | $1.05 M(+20.0%) |
| Mar 2021 | $871.40 K(-29.6%) | $871.40 K |
| Mar 2020 | $1.24 M | - |
FAQ
- What is Virax Biolabs Group Limited annual total liabilities?
- What is the all time high annual total liabilities for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual total liabilities year-on-year change?
- What is Virax Biolabs Group Limited quarterly total liabilities?
- What is the all time high quarterly total liabilities for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited quarterly total liabilities year-on-year change?
What is Virax Biolabs Group Limited annual total liabilities?
The current annual total liabilities of VRAX is $345.20 K
What is the all time high annual total liabilities for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual total liabilities is $1.25 M
What is Virax Biolabs Group Limited annual total liabilities year-on-year change?
Over the past year, VRAX annual total liabilities has changed by -$563.20 K (-62.00%)
What is Virax Biolabs Group Limited quarterly total liabilities?
The current quarterly total liabilities of VRAX is $1.03 M
What is the all time high quarterly total liabilities for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high quarterly total liabilities is $1.25 M
What is Virax Biolabs Group Limited quarterly total liabilities year-on-year change?
Over the past year, VRAX quarterly total liabilities has changed by $0.00 (0.00%)